Prime Medicine Growth Metrics (2021-2025) | PRME

Growth Metrics Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Growth Ratios
EBITDA Margin Growth (1y) 0.42M2.10M
EBITDA Margin (QoQ) 2.31M-0.16M-0.11M0.06M
EBIT Margin Growth (1y) 0.46M2.15M
EBIT Margin (QoQ) 2.39M-0.16M-0.12M0.04M
EBT Margin Growth (1y) 0.42M2.08M
EBT Margin (QoQ) 2.32M-0.16M-0.11M0.04M
Enterprise Value Growth (1y) 31.67%-12.78%-48.18%-118.15%-17.05%59.38%16.14%21.39%-6.30%-61.29%31.24%37.83%-22.16%
Enterprise Value Growth (3y) 5.26%9.59%5.11%-2.16%-14.98%
Enterprise Value (QoQ) -26.41%35.25%43.84%-48.66%-108.64%14.93%17.32%20.24%27.59%-75.63%22.50%-7.87%-9.86%25.13%29.93%-111.94%
FCF Margin Growth (1y) 0.83M1.01M
FCF Margin (QoQ) 1.37M-0.42M-0.03M0.10M
Net Margin Growth (1y) 0.42M2.10M
Net Margin (QoQ) 2.32M-0.16M-0.11M0.06M
Operating Margin Growth (1y) 0.46M2.15M
Operating Margin (QoQ) 2.39M-0.16M-0.12M0.04M
Return on Assets Growth (1y) -49.00-40.00-26.00-8.0029.0016.0011.0014.00
Return on Assets (QoQ) 2.00-10.00-16.00-25.0011.005.002.0012.00-2.00-1.006.00
Return on Capital Employed Growth (1y) -83.00-50.00-27.00-8.0055.0019.009.0019.00
Return on Capital Employed (QoQ) 1.00-14.00-22.00-48.0035.009.00-3.0015.00-1.00-2.007.00
Return on Equity Growth (1y) -131.00-149.00140.00-62.00-41.00-34.007.00-47.00-139.00-66.00
Return on Equity Growth (3y) -311.00-249.00
Return on Equity (QoQ) -4.00-331.00215.00-12.00-21.00-42.0013.0010.00-15.00-1.00-41.00-82.0058.00
Return on Invested Capital Growth (1y) -123.00-147.00123.00-67.00-42.00-46.00
Return on Invested Capital (QoQ) 3.00-314.00203.00-14.00-21.00-44.0012.0012.00
Return on Sales Growth (1y) 0.00M0.03M0.02M
Return on Sales (QoQ) -0.03M0.01M0.02M-0.00M-0.00M404.00